Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan
- PMID: 35198629
- PMCID: PMC8859504
- DOI: 10.1183/23120541.00551-2021
Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan
Abstract
Treatment outcomes of childhood XDR-TB patients in Pakistan are better than in adult patients but still disappointing https://bit.ly/3rkQ9sw.
Copyright ©The authors 2022.
Conflict of interest statement
Conflict of interest: None declared
References
-
- World Health Organization . WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva, World Health Organization, 2019. - PubMed
-
- World Health Organization . WHO announces updated definitions of extensively drug-resistant tuberculosis. www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-ex... Date last updated: 27 January 2021.
-
- Solodovnikova V, Kumar AM, Hurevich H, et al. . Effectiveness and safety of delamanid-or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: a nationwide study from Belarus, 2015–19. Monaldi Arch Chest Dis 2021; 91: 1646. doi:10.4081/monaldi.2021.1646 - DOI - PubMed
LinkOut - more resources
Full Text Sources